Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.

37,449

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,872

Class I recallsReasonable probability of serious health consequences

24,509

Class II recallsTemporary or medically reversible health consequences

2,932

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of Assurance of Sterility 2,096 recalls

Newest recallhttps://www.fsis.usda.gov/recalls-alerts/fsis-issues-public-health-alert-meat-and-poultry-products-due-misbranding-andPublished November 6, 2026

Most affected stateHawaii 200 recalls mention this state

State: MD ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated November 8, 2026 ET

Summary (Year to date)

1,956 recalls have been announced year to date.
Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
The highest complete period was Jun 2026 (300).
Nov 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

Download CSV

Recalls by class
Class	Recalls
Class II	24,509
Class I	9,872
Class III	2,932
Not Yet Classified	2

FDA Recall OngoingHistorical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 50 mg, a) 30-count bottle (NDC: 13668-409-30), b) 90-count bottle (NDC: 13668-409-90), c) 1000-count bottle (NDC: 13668-409-10), Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 30-count (NDC: 13668-115-30), b) 90-count (NDC: 13668-115-90), c) 1000-count (NDC: 13668-115-10) per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana Inda

by Torrent Pharma Inc.

Reason: CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable daily intake level of 0.083 parts per million.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 30, 2019Historical recordClass III

Oxytocin 30 Units added to NS 500 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 503 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-706-50.

by Advanced Pharma Inc.

Reason: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 30, 2019Historical recordClass III

Oxytocin 20 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 1002 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-703-99.

by Advanced Pharma Inc.

Reason: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: October 30, 2019Historical recordClass III

Oxytocin 10 Units added to NS 1000 mL (oxytocin and 0.9% Sodium Chloride) Injectable Solution, Approximately 1001 mL Sterile single use bag, Rx only, Avella of Houston, 9265 Kirby Dr., Houston, TX 77054, NDC 42852-730-99.

by Advanced Pharma Inc.

Reason: Superpotent Drug: product may contain concentrations of oxytocin higher than what is represented on the label.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 17, 2019Historical recordClass II

Ardent Mills, LLC

Product: MEMBERS MARK SELF RISE FLR 25LB
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 17, 2019Historical recordClass II

Ardent Mills, LLC

Product: WESTCREEK H&R SELF RISE AP FLR 25LB and 50LB
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 17, 2019Historical recordClass II

Ardent Mills, LLC

Product: HILLTOP HEARTH SELF RISE FLR 25LB and 50LB
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall United States TerminatedTerminated: May 17, 2019Historical recordClass II

Ardent Mills, LLC

Product: ARDENT H&R SR FLR, 25LB, 50 LB, and 25LB (PC)-309951, packag…
Reason: Ardent Mills is voluntarily recalling certain lots of Self-Rising Flour because it has the potential to be contaminated with Salmonella.
Published: February 27, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: April 4, 2023Historical recordClass I

Levetiracetam in 0.54 % Sodium Chloride Injection 1,500/mg/100mL (15mg/mL), For intravenous Infusion Only, 1 x 100 mL Infusion bag, Manufactured by: Gland Pharma Limited Hyderabad - 500 043, India Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540 UPC 343598637525 ---- NDC 43598-637-52

by Dr. Reddy's Laboratories, Inc.

Reason: Labeling: Label Error on Declared Strength; the pre-printed text on the primary infusion bag and the NDC incorrectly identifies the product as Levetiracetam in 0.75% Sodium Chloride (1000 mg/100 mL) however, the external foil pouch correctly identifies the product as Levetiracetam in 0.54% Sodium Chloride Injection (1,500/100 mL).
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 30, 2021Historical recordClass II

Glutathione Injection, 200 mg/mL, 10 mL, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684

by Promise Pharmacy, LLC

Reason: Lack of sterility assurance.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 30, 2021Historical recordClass II

Vitamin D3 50,000iu/mL, injection 5 mL, Rx Only, Promise Pharmacy Compounding Specialists 31818 US Hwy 19N, Palm Harbor, FL 34684

by Promise Pharmacy, LLC

Reason: Lack of sterility assurance.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: January 26, 2021Historical recordClass III

Esomeprazole Magnesium Delayed-Release Capsules USP, 40mg*, a) 90-count bottle (NDC 43598-510-90) b) 1000 count bottle (NDC 43598-510-10), Rx only, Mfd By: Dr. Reddy's Laboratories Limited Bachupally - 500 090 INDIA.

by Dr. Reddy's Laboratories, Inc.

Reason: Discoloration: Esomeprazole Magnesium DR Capsules (40mg) may contain brown pellets.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 29, 2023Historical recordClass II

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39961 3, NDC 50428-1252-4.

by Tris Pharma Inc.

Reason: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 29, 2023Historical recordClass II

infants* IBUPROFEN, Concentrated Ibuprofen Oral Suspension, USP (NSAID), 50 mg per 1.25 mL, Dye-Free Berry Flavor, 1 FL OZ (30 mL) bottle, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-125-24.

by Tris Pharma Inc.

Reason: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: March 29, 2023Historical recordClass II

Infants' Ibuprofen, Concentrated Ibuprofen Oral Suspension, USP, (NSAID), 50 mg per 1.25 mL, Dye Free, Non-staining Berry Flavor, 0.5 FL OZ (15 mL) bottle, Distributed by: CVS Pharmacy, Inc., One CVS Drive, Woonsocket, RI 02895, UPC 0 50428 39338 3, NDC 59779-925-23.

by Tris Pharma Inc.

Reason: Superpotent Drug: recalled lots may have higher concentration of ibuprofen than amount labeled.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 8, 2020Historical recordClass III

Diltiazem HCl CD capsules, 360 mg, 90-count bottles, Rx Only, Manufactured for: Oceanside Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7 Canada; NDC 68682-521-01.

by Valeant Pharmaceuticals North America LLC

Reason: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 8, 2020Historical recordClass III

Cardizem CD (diltiazem HCl) capsules, 300 mg, packaged in a) 30-count bottles (NDC 0187-0798-30); and b) 90-count bottles (NDC 0187-0798-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

by Valeant Pharmaceuticals North America LLC

Reason: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 8, 2020Historical recordClass III

Cardizem CD (diltiazem HCl) capsules, 240 mg, packaged in a) 30-count bottles (NDC 0187-0797-30); and b) 90-count bottles (NDC 0187-0797-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

by Valeant Pharmaceuticals North America LLC

Reason: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Published: February 20, 2019
Distribution: Nationwide

View recall →

FDA Recall TerminatedTerminated: July 8, 2020Historical recordClass III

Cardizem CD (diltiazem HCl) capsules, 180 mg, packaged in a) 30-count bottles (NDC 0187-0796-30); and b) 90-count bottles (NDC 0187-0796-42), Rx Only, Manufactured for: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807 USA; By: Valeant Pharmaceuticals International, Inc., Steinbach, MB R5G 1Z7, Canada.

by Valeant Pharmaceuticals North America LLC

Reason: Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.
Published: February 20, 2019
Distribution: Nationwide

View recall →

Data last updated: November 8, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.